GLSI

Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc. (GLSI) has 3 SEC Form 4 filings (5 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 30, 2026.

The most active filer is CEO and CFO Patel Snehal with 5 filings.

  • Industry:Biotechnology
  • CEO:Snehal S. Patel
  • Employees:13
  • HQ:Stafford, TX, US
  • IPO:2020-09-25

Insider Buying

$97K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$187.9M

latest known value

Source
Purchase$20KJul 30SEC ↗
Purchase$9KJul 30SEC ↗
Purchase$20KJul 29SEC ↗
Patel SnehalFirst filing
Purchase$33KJul 27SEC ↗
Patel SnehalFirst filing
Purchase$14KJul 27SEC ↗

Related companies

Greenwich LifeSciences, Inc. is in the Healthcare sector.